Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000914208-25-000042·COLLEGIUM PHARMACEUTICAL, INC
Schedule 13G ownership disclosure
Collegium Pharmaceutical Inc
Common Stock · CUSIP: 19459J104
Event date: 2024-12-31
- Filing-level shares
- 1,775,760.00
- Percent of class
- 5.5%
- Invesco Ltd.
Shares: 1,775,760.00 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-25-000042
- Form type
- SCHEDULE 13G
- Filer
- COLLEGIUM PHARMACEUTICAL, INC
- CIK
- CIK 1267565
- Filed
- Feb 07, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership